Developments in antiplatelet therapy for acute coronary syndromes and considerations for long-term management

Author： Cowley Michael J. Kuritzky Louis

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.25, Iss.6, 2009-06, pp. : 1477-1490

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tailoring Antiplatelet Therapy in Acute Coronary Syndromes: The Thin Red Line

Cardiology, Vol. 126, Iss. 4, 2013-09 ,pp. : 230-232

Karger

Access to resources Recommend Favorite

Predictors of bleeding risk and long-term mortality in patients with acute coronary syndromes

By Cohen Marc

Current Medical Research and Opinion, Vol. 21, Iss. 3, 2005-03 ,pp. : 439-446

Informa Healthcare

Access to resources Recommend Favorite

Response to Dual Antiplatelet Therapy Does Not Impact Bleeding Risks in Patients Undergoing Oral Surgery after Acute Coronary Syndromes

Cardiology, Vol. 132, Iss. 2, 2015-07 ,pp. : 119-123

Karger

Access to resources Recommend Favorite

Triple versus Dual Antiplatelet Therapy in Acute Coronary Syndromes: Adding Cilostazol to Aspirin and Clopidogrel?

Cardiology, Vol. 126, Iss. 4, 2013-10 ,pp. : 233-243

Karger

Access to resources Recommend Favorite

Pre‐treatment with dual antiplatelet therapy in patients with non‐ST‐segment elevation acute coronary syndromes undergoing percutaneous coronary intervention

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 10, 2015-10 ,pp. : 1032-1037

John Wiley & Sons Inc

Access to resources Recommend Favorite